The University of Nottingham is offering a fully funded PhD position focused on investigating how a novel RUNX1 oncoprotein causes acute myeloid leukaemia. The project is supervised by Assistant Professor Sophie Kellaway, along with Professors Alex Thompson, John Schwabe, and David Heery, forming a multidisciplinary team with expertise in blood cancer, chromatin, gene regulation, biochemistry, structural biology, and bioinformatics. This opportunity is ideal for highly motivated students interested in cancer research, particularly in the areas of blood cancer, stem cells, and gene regulation.

The PhD is part of the MRC AIM Doctoral Training Partnership, which offers a range of projects across the Universities of Birmingham, Leicester, and Nottingham. The program provides comprehensive training in translational research, with some projects involving industry partners. Applicants will benefit from a collaborative research environment and access to cutting-edge resources and expertise.

Eligibility requires a First or Upper Second class UK honours degree (or equivalent international qualification) in a relevant subject. A master’s degree and/or research experience in related fields such as biology, medical science, biochemistry, or bioinformatics is advantageous. The program welcomes applications from home, EU, and international students, though international recruitment is capped at 30% of the cohort due to funding stipulations.

The position is fully funded, covering both stipend and tuition fees. The application process involves completing the AIM 2026 application form, submitting a 2-page CV, and providing a screenshot confirming completion of the anonymous Equality, Diversity and Inclusion (ED&I) form. Applications must be submitted as a single document to [email protected] by midday (GMT) on 9 January 2026. Applicants are encouraged to contact the supervisors to discuss their fit for the program and to attend one of the applicant webinars for further guidance.

This PhD project offers a unique opportunity to contribute to the understanding of acute myeloid leukaemia and to develop expertise in advanced research techniques within a supportive academic environment at the University of Nottingham.